Catecholaminergic polymorphic ventricular tachycardia overview: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Catecholaminergic polymorphic ventricular tachycardia}} '''For patient information, click here''' {{CMG}}; {{AE}} {{SK}} ==Cate...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Catecholaminergic polymorphic ventricular tachycardia}} | {{Catecholaminergic polymorphic ventricular tachycardia}} | ||
'''For patient information, click [[ | '''For patient information, click [[Catecholaminergic polymorphic ventricular tachycardia(patient information)|here]]''' | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
| Line 11: | Line 11: | ||
==[[Catecholaminergic polymorphic ventricular tachycardia historical perspective|Historical Perspective]]== | ==[[Catecholaminergic polymorphic ventricular tachycardia historical perspective|Historical Perspective]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia classification|Classification]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia pathophysiology|Pathophysiology]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia causes|Causes]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia differential diagnosis|Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia risk factors|Risk Factors]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia screening|Screening]]== | ||
==[[ | ==[[Catecholaminergic polymorphic ventricular tachycardia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice|Diagnostic study of choice]] | [[Catecholaminergic polymorphic ventricular tachycardia history and symptoms|History and Symptoms]] | [[Catecholaminergic polymorphic ventricular tachycardia physical examination|Physical Examination]] | [[Catecholaminergic polymorphic ventricular tachycardia laboratory findings|Laboratory Findings]] | [[Catecholaminergic polymorphic ventricular tachycardia electrocardiogram|Electrocardiogram]] | [[Catecholaminergic polymorphic ventricular tachycardia x ray|X-Ray Findings]] | [[Catecholaminergic polymorphic ventricular tachycardia echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Catecholaminergic polymorphic ventricular tachycardia CT scan|CT-Scan Findings]] | [[Catecholaminergic polymorphic ventricular tachycardia MRI|MRI Findings]] | [[Catecholaminergic polymorphic ventricular tachycardia other imaging findings|Other Imaging Findings]] | [[Catecholaminergic polymorphic ventricular tachycardia other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia medical therapy|Medical Therapy]] | [[Catecholaminergic polymorphic ventricular tachycardia interventions|Interventions]] | [[Catecholaminergic polymorphic ventricular tachycardia surgery|Surgery]] | [[Catecholaminergic polymorphic ventricular tachycardia primary prevention|Primary Prevention]] | [[Catecholaminergic polymorphic ventricular tachycardia secondary prevention|Secondary Prevention]] | [[Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Catecholaminergic polymorphic ventricular tachycardia future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia case study one|Case #1]] | ||
[[Category: (name of the system)]] | [[Category: (name of the system)]] | ||
Revision as of 16:57, 22 July 2020
|
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
|
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Catecholaminergic polymorphic ventricular tachycardia overview On the Web |
|
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia overview |
|
FDA on Catecholaminergic polymorphic ventricular tachycardia overview |
|
CDC on Catecholaminergic polymorphic ventricular tachycardia overview |
|
Catecholaminergic polymorphic ventricular tachycardia overview in the news |
|
Blogs on Catecholaminergic polymorphic ventricular tachycardia overview |
|
Risk calculators and risk factors for Catecholaminergic polymorphic ventricular tachycardia overview |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies